Skip to content
HowShorted

DermTech, Inc. short interest in 2021

In 2021, DermTech, Inc.'s disclosed short interest ran from 7.93% of shares outstanding on 15 Jan 2021 to 16.77% on 31 Dec 2021, a change of +8.84 percentage points. The year's high was 18.66% on 14 May 2021 and its low 4.55% on 12 Feb 2021, averaging 14.50% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.80 days on 15 Oct 2021. Full history: DermTech, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for DermTech, Inc. in 2021

2021 in figures

Start of year
7.93% (15 Jan 2021)
End of year
16.77% (31 Dec 2021)
Change
+8.84 pp
High
18.66% (14 May 2021)
Low
4.55% (12 Feb 2021)
Average
14.50%
Highest days to cover
14.80 (15 Oct 2021)
SEC filings marked
9

Every report in 2021

DermTech, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20217.93%1.15results (8-K)
29 Jan 20219.26%1.62
12 Feb 20214.55%1.00
26 Feb 20217.90%1.00
15 Mar 20218.76%1.49results (8-K), 10-K filed
31 Mar 202116.20%3.06
15 Apr 202116.64%5.74
30 Apr 202117.71%3.08
14 May 202118.66%4.7410-Q filed, results (8-K)
28 May 202118.20%7.34
15 Jun 202117.13%6.36
30 Jun 202118.55%5.72
15 Jul 202117.71%5.34
30 Jul 202115.79%8.21
13 Aug 202115.17%6.6010-Q filed, results (8-K)
31 Aug 202114.47%11.43
15 Sep 202114.00%13.16
30 Sep 202114.90%12.61
15 Oct 202115.42%14.80
29 Oct 202115.50%10.29
15 Nov 202114.76%6.0310-Q filed, results (8-K)
30 Nov 202116.04%8.29
15 Dec 202116.00%6.04
31 Dec 202116.77%6.36

See also: DermTech, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.